SoftOx doses first patient in SIS-03 proof-of-concept trial

BSF secures exclusive global commercialisation partnership for ETSYL

Aureka Biotechnologies raises USD100m to build biological world model for drug discovery

Kodiak Sciences enrols first patients in KSI-501 Phase 3 ALTO trial in patients with diabetic macular oedema

AbCellera reports positive Phase 2 results for menopause treatment ABCL635

Bristol Myers Squibb to invest USD2.3bn in Houston manufacturing campus

BeOne Medicines and Revolution Medicines expand oncology collaboration

Almirall partners with CrystalO to develop small molecules for medical dermatology

Sobi partners with Innate Pharma to advance lacutamab in T-cell lymphoma

Saniona grants AstronauTx worldwide rights to neurological disease programme

Oculis signs agreement to acquire Privosegtor from Accure Therapeutics

Biophytis receives Brazilian approval for Phase 2 obesity trial of BIO101

ImmuPharma selects Kymos Group as bioanalytical partner for Kapiglucagon

Neurocrine Biosciences initiates Phase 1 study of GLP-1/GIP/glucagon receptor triple agonist

Akeso Advances reports first patient dosed in AK146D1 combined with ivonescimab breast cancer study